Summary

MARKET OUTLOOK
According to Triton’s report analysis, the global artificial intelligence (AI) in healthcare market is expected to witness revenue growth at a CAGR of 37.14% over the forecast period 2024-2032.
The market’s growth is prompted by varied factors, such as AI adoption supported by a large volume of healthcare data, growing governmental support, and rising start-ups in AI and machine learning. Big data technologies play a crucial role in biomedical and healthcare fields, handling the immense volume of biological and clinical data sourced from laboratories and medical research centers. This data, primarily from patient records, requires AI-driven analysis to unveil innovative approaches to enhancing healthcare standards.
However, cost constraints and low return on investment, slow adoption of AI-based technologies, and challenges in sustaining data security hamper the overall development of the AI in healthcare market.
REGIONAL OUTLOOK
The global AI in healthcare market covers the Middle East and Africa, North America, Asia-Pacific, Latin America, and Europe regions.
Asia-Pacific is estimated to witness fast growth in the AI in healthcare market over the forecast years. Government and private sector investments, coupled with the emergence of startups, are pivotal factors propelling the regional market forward. Additionally, the development of new technologies in artificial intelligence (AI) for healthcare is further bolstering growth in the region. In particular, AI in healthcare within the region finds significant adoption and application in various aspects of the healthcare industry, notably precision medicine and genome testing.
COMPETITIVE OUTLOOK
The major companies in the artificial intelligence in healthcare market comprise General Vision Inc, GE Healthcare, IBM Corporation, Koninklijke Philips NV, Microsoft Corporation, Google LLC, Intel Corporation, NVIDIA Corporation, Oncora Medical, Medtronic Plc, Recursion Pharmaceuticals Inc, Stryker Corporation, and Siemens Healthineers AG.
Google LLC, a subsidiary of Alphabet Inc, is a prominent provider of Internet search and advertising services. Its diverse business areas encompass advertising, search, platforms and operating systems, enterprise, and hardware products. Notable offerings within its expansive portfolio include Google Search, Google Chrome, Google Docs, Google Calendar, Gmail, Google Groups, YouTube, etc. With a global presence spanning the Americas, Europe, Asia-Pacific, Africa, and the Middle East, Google is headquartered in California, US.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. PORTER’S FIVE FORCES ANALYSIS
2.1.1. BUYERS POWER
2.1.2. SUPPLIERS POWER
2.1.3. SUBSTITUTION
2.1.4. NEW ENTRANTS
2.1.5. INDUSTRY RIVALRY
2.2. MARKET MATURITY ANALYSIS
2.3. VALUE CHAIN ANALYSIS
2.3.1. DATA WAREHOUSE
2.3.2. ARTIFICIAL INTELLIGENCE (AI) ANALYSIS
2.3.3. SOFTWARE DEVELOPMENT
2.4. KEY BUYING CRITERIA
2.4.1. APPLICATION
2.4.2. TECHNOLOGY
2.4.3. INTEGRATION WITH EXISTING INFRASTRUCTURE
2.5. REGULATORY FRAMEWORK
2.6. KEY MARKET STRATEGIES
2.6.1. ACQUISITIONS
2.6.2. PRODUCT LAUNCHES
2.6.3. COLLABORATIONS
2.7. MARKET DRIVERS
2.7.1. ADOPTION OF AI BEING SUPPORTED BY LARGE VOLUMES OF HEALTHCARE DATA
2.7.2. PERSONALIZED MEDICINE IN TESTS FOR CLINICAL DECISION-MAKING
2.7.3. GROWING PROACTIVE GOVERNMENT SUPPORT AND INVESTMENTS IN AI R&D
2.7.4. INCREASING START-UPS IN AI AND MACHINE LEARNING
2.8. MARKET CHALLENGES
2.8.1. COST CONSTRAINTS AND A LOW RETURN ON INVESTMENT (ROI)
2.8.2. CHALLENGES IN SUSTAINING DATA SECURITY
2.8.3. SLOW ADOPTION OF AI-BASED TECHNOLOGIES
2.9. MARKET OPPORTUNITIES
2.9.1. EXPANDING APPLICATIONS OF AI IN THE HEALTHCARE INDUSTRY
2.9.2. RISING DEMAND FOR AI IN DRUG DISCOVERY
2.9.3. STRONG FOCUS ON THE DEVELOPMENT OF PRECISION MEDICINE AND PERSONALIZED DRUGS
2.9.4. AI USED TO ESTABLISH A REAL-TIME MONITORING SYSTEM
2.10. ANALYST PERSPECTIVE
3. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET - BY SOLUTION
3.1. SOFTWARE
3.2. SERVICES
3.3. HARDWARE
4. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET - BY TECHNOLOGY
4.1. NATURAL LANGUAGE PROCESSING
4.2. QUERYING METHOD
4.3. CONTEXT AWARE PROCESSING
4.4. DEEP LEARNING
5. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET - BY TYPE
5.1. ROBOT-ASSISTED SURGERY
5.2. VIRTUAL NURSING ASSISTANT
5.3. ADMINISTRATIVE WORKFLOW ASSISTANCE
5.4. FRAUD DETECTION
5.5. DOSAGE ERROR REDUCTION
5.6. CLINICAL TRIAL PARTICIPANT IDENTIFIER
5.7. PRELIMINARY DIAGNOSIS
5.8. OTHER TYPES
6. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET - BY INDUSTRY VERTICAL
6.1. HEALTHCARE PROVIDERS
6.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
6.3. PAYERS
6.4. ACOS AND MCOS
6.5. PATIENTS
7. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET – BY REGIONAL OUTLOOK
7.1. NORTH AMERICA
7.1.1. MARKET BY SOLUTION
7.1.2. MARKET BY TECHNOLOGY
7.1.3. MARKET BY TYPE
7.1.4. MARKET BY INDUSTRY VERTICAL
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED STATES
7.1.5.1.1. UNITED STATES ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.1.5.2. CANADA
7.1.5.2.1. CANADA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.2. EUROPE
7.2.1. MARKET BY SOLUTION
7.2.2. MARKET BY TECHNOLOGY
7.2.3. MARKET BY TYPE
7.2.4. MARKET BY INDUSTRY VERTICALS
7.2.5. COUNTRY ANALYSIS
7.2.5.1. GERMANY
7.2.5.1.1. GERMANY ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.2.5.2. UNITED KINGDOM
7.2.5.2.1. UNITED KINGDOM ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.2.5.3. FRANCE
7.2.5.3.1. FRANCE ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.2.5.4. ITALY
7.2.5.4.1. ITALY MARKET FORECAST & PROSPECTS
7.2.5.5. SPAIN
7.2.5.5.1. SPAIN ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.2.5.6. NETHERLANDS
7.2.5.6.1. NETHERLANDS ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.2.5.7. REST OF EUROPE
7.2.5.7.1. REST OF EUROPE ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.3. ASIA-PACIFIC
7.3.1. MARKET BY SOLUTION
7.3.2. MARKET BY TECHNOLOGY
7.3.3. MARKET BY TYPE
7.3.4. MARKET BY INDUSTRY VERTICAL
7.3.5. COUNTRY ANALYSIS
7.3.5.1. CHINA
7.3.5.1.1. CHINA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.3.5.2. JAPAN
7.3.5.2.1. JAPAN ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.3.5.3. INDIA
7.3.5.3.1. INDIA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.3.5.4. SOUTH KOREA
7.3.5.4.1. SOUTH KOREA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.3.5.5. AUSTRALIA & NEW ZEALAND
7.3.5.5.1. AUSTRALIA & NEW ZEALAND ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.3.5.6. ASEAN COUNTRIES
7.3.5.6.1. ASEAN COUNTRIES ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.3.5.7. REST OF ASIA-PACIFIC
7.3.5.7.1. REST OF ASIA-PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.4. LATIN AMERICA
7.4.1. MARKET BY SOLUTION
7.4.2. MARKET BY TECHNOLOGY
7.4.3. MARKET BY TYPE
7.4.4. MARKET BY INDUSTRY VERTICAL
7.4.5. COUNTRY ANALYSIS
7.4.5.1. BRAZIL
7.4.5.1.1. BRAZIL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.4.5.2. MEXICO
7.4.5.2.1. MEXICO ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.4.5.3. REST OF LATIN AMERICA
7.4.5.3.1. REST OF LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.5. MIDDLE EAST AND AFRICA
7.5.1. MARKET BY SOLUTION
7.5.2. MARKET BY TECHNOLOGY
7.5.3. MARKET BY TYPE
7.5.4. MARKET BY INDUSTRY VERTICAL
7.5.5. COUNTRY ANALYSIS
7.5.5.1. UNITED ARAB EMIRATES
7.5.5.1.1. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECT
7.5.5.2. SAUDI ARABIA
7.5.5.2.1. SAUDI ARABIA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.5.5.3. TURKEY
7.5.5.3.1. TURKEY ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.5.5.4. SOUTH AFRICA
7.5.5.4.1. SOUTH AFRICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.5.5.5. REST OF MIDDLE EAST & AFRICA
7.5.5.5.1. REST OF MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
8. COMPETITIVE LANDSCAPE
8.1. GE HEALTHCARE
8.1.1. OVERVIEW
8.1.2. PRODUCT LIST
8.1.3. KEY STRENGTHS
8.1.4. KEY CHALLENGES
8.2. GENERAL VISION INC
8.2.1. OVERVIEW
8.2.2. PRODUCT LIST
8.3. GOOGLE LLC
8.3.1. OVERVIEW
8.3.2. PRODUCT LIST
8.3.3. KEY STRENGTHS
8.3.4. KEY CHALLENGES
8.4. IBM CORPORATION
8.4.1. OVERVIEW
8.4.2. PRODUCT LIST
8.4.3. KEY STRENGTHS
8.4.4. KEY CHALLENGES
8.5. INTEL CORPORATION
8.5.1. OVERVIEW
8.5.2. PRODUCT LIST
8.5.3. KEY STRENGTHS
8.5.4. KEY CHALLENGES
8.6. KONINKLIJKE PHILIPS NV
8.6.1. COMPANY OVERVIEW
8.6.2. PRODUCTS
8.6.3. KEY STRENGTHS
8.6.4. KEY CHALLENGES
8.7. MEDTRONIC PLC
8.7.1. COMPANY OVERVIEW
8.7.2. PRODUCT LIST
8.7.3. KEY STRENGTHS
8.7.4. KEY CHALLENGES
8.8. MICROSOFT CORPORATION
8.8.1. COMPANY OVERVIEW
8.8.2. PRODUCT LIST
8.8.3. KEY STRENGTHS
8.8.4. KEY CHALLENGES
8.9. NVIDIA CORPORATION
8.9.1. OVERVIEW
8.9.2. PRODUCT LIST
8.9.3. KEY STRENGTHS
8.9.4. KEY CHALLENGES
8.10. ONCORA MEDICAL
8.10.1. OVERVIEW
8.10.2. PRODUCT LIST
8.11. RECURSION PHARMACEUTICALS INC
8.11.1. OVERVIEW
8.11.2. PRODUCTS
8.12. STRYKER CORPORATION
8.12.1. OVERVIEW
8.12.2. PRODUCT LIST
8.12.3. KEY STRENGTHS
8.12.4. KEY CHALLENGES
8.13. SIEMENS HEALTHINEERS AG
8.13.1. OVERVIEW
8.13.2. PRODUCT LIST
8.13.3. KEY STRENGTHS
8.13.4. KEY CHALLENGES
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1. OBJECTIVES OF STUDY
9.1.2. SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1. PRIMARY DATA SOURCES
9.2.2. SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1. EVALUATION OF PROPOSED MARKET
9.3.2. IDENTIFICATION OF DATA SOURCES
9.3.3. ASSESSMENT OF MARKET DETERMINANTS
9.3.4. DATA COLLECTION
9.3.5. DATA VALIDATION & ANALYSIS

LIST OF TABLES
TABLE 1: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY REGIONAL OUTLOOK, HISTORICAL YEARS, 2020-2023 (IN $ MILLION)
TABLE 2: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY REGIONAL OUTLOOK, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF COLLABORATIONS
TABLE 6: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY SOLUTION, 2024-2032 (IN $ MILLION)
TABLE 7: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)
TABLE 8: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TYPE, 2024-2032 (IN $ MILLION)
TABLE 9: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 10: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY REGIONAL OUTLOOK, HISTORICAL YEARS, 2020-2023 (IN $ MILLION)
TABLE 11: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY REGIONAL OUTLOOK, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: NORTH AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 13: NORTH AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY SOLUTION, 2024-2032 (IN $ MILLION)
TABLE 14: NORTH AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)
TABLE 15: NORTH AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TYPE, 2024-2032 (IN $ MILLION)
TABLE 16: NORTH AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 17: EUROPE ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 18: EUROPE ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY SOLUTION, 2024-2032 (IN $ MILLION)
TABLE 19: EUROPE ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)
TABLE 20: EUROPE ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TYPE, 2024-2032 (IN $ MILLION)
TABLE 21: EUROPE ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 22: ASIA-PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 23: ASIA-PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY SOLUTION, 2024-2032 (IN $ MILLION)
TABLE 24: ASIA-PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)
TABLE 25: ASIA-PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TYPE, 2024-2032 (IN $ MILLION)
TABLE 26: ASIA-PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 27: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 28: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY SOLUTION, 2024-2032 (IN $ MILLION)
TABLE 29: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)
TABLE 30: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TYPE, 2024-2032 (IN $ MILLION)
TABLE 31: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 32: MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 33: MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY SOLUTION, 2024-2032 (IN $ MILLION)
TABLE 34: MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)
TABLE 35: MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TYPE, 2024-2032 (IN $ MILLION)
TABLE 36: MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)

LIST OF FIGURES
FIGURE 1: PORTER’S FIVE FORCES ANALYSIS
FIGURE 2: MARKET MATURITY ANALYSIS
FIGURE 3: VALUE CHAIN ANALYSIS
FIGURE 4: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY SOLUTION, 2023 & 2032 (IN %)
FIGURE 5: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY SOFTWARE, 2024-2032 (IN $ MILLION)
FIGURE 6: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY SERVICES, 2024-2032 (IN $ MILLION)
FIGURE 7: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY HARDWARE, 2024-2032 (IN $ MILLION)
FIGURE 8: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023 & 2032 (IN %)
FIGURE 9: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY NATURAL LANGUAGE PROCESSING, 2024-2032 (IN $ MILLION)
FIGURE 10: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY QUERYING METHOD, 2024-2032 (IN $ MILLION)
FIGURE 11: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY CONTEXT AWARE PROCESSING, 2024-2032 (IN $ MILLION)
FIGURE 12: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY DEEP LEARNING, 2024-2032 (IN $ MILLION)
FIGURE 13: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TYPE, 2023 & 2032 (IN %)
FIGURE 14: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY ROBOT-ASSISTED SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 15: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY VIRTUAL NURSING ASSISTANT, 2024-2032 (IN $ MILLION)
FIGURE 16: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY ADMINISTRATIVE WORKFLOW ASSISTANCE, 2024-2032 (IN $ MILLION)
FIGURE 17: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY FRAUD DETECTION, 2024-2032 (IN $ MILLION)
FIGURE 18: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY DOSAGE ERROR REDUCTION, 2024-2032 (IN $ MILLION)
FIGURE 19: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY CLINICAL TRIAL PARTICIPANT IDENTIFIER, 2024-2032 (IN $ MILLION)
FIGURE 20: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY PRELIMINARY DIAGNOSIS, 2024-2032 (IN $ MILLION)
FIGURE 21: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY OTHER TYPES, 2024-2032 (IN $ MILLION)
FIGURE 22: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY INDUSTRY VERTICAL, 2023 & 2032 (IN %)
FIGURE 23: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY HEALTHCARE PROVIDERS, 2024-2032 (IN $ MILLION)
FIGURE 24: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2024-2032 (IN $ MILLION)
FIGURE 25: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY PAYERS, 2024-2032 (IN $ MILLION)
FIGURE 26: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY ACOS AND MCOS, 2024-2032 (IN $ MILLION)
FIGURE 27: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY PATIENTS, 2024-2032 (IN $ MILLION)
FIGURE 28: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY REGIONAL OUTLOOK, 2023 & 2032 (IN %)
FIGURE 29: UNITED STATES ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 30: CANADA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 31: GERMANY ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 32: UNITED KINGDOM ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 33: FRANCE ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 34: ITALY ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 35: SPAIN ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 36: NETHERLANDS ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 37: REST OF EUROPE ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 38: CHINA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 39: JAPAN ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 40: INDIA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 41: SOUTH KOREA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 42: AUSTRALIA & NEW ZEALAND ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 43: ASEAN COUNTRIES ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 44: REST OF ASIA-PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 45: BRAZIL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 46: MEXICO ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 47: REST OF LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 48: UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 49: SAUDI ARABIA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 50: TURKEY ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 51: SOUTH AFRICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 52: REST OF MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)